PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of frontneurosciLink to Publisher's site
 
Front Neurosci. 2017; 11: 127.
Published online 2017 March 20. doi:  10.3389/fnins.2017.00127
PMCID: PMC5357634

Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control

Abstract

Many physiological processes fluctuate throughout the day/night and daily fluctuations are observed in brain and peripheral levels of several hormones, neuropeptides and transmitters. In turn, mediators under the “control” of the “master biological clock” reciprocally influence its function. Dysregulation in the rhythmicity of hormone release as well as hormone receptor sensitivity and availability in different tissues, is a common risk-factor for multiple clinical conditions, including psychiatric and metabolic disorders. At the same time circadian rhythms remain in a strong, reciprocal interaction with the hypothalamic-pituitary-adrenal (HPA) axis. Recent findings point to a role of circadian disturbances and excessive stress in the development of obesity and related food consumption and metabolism abnormalities, which constitute a major health problem worldwide. Appetite, food intake and energy balance are under the influence of several brain neuropeptides, including the orexigenic agouti-related peptide, neuropeptide Y, orexin, melanin-concentrating hormone and relaxin-3. Importantly, orexigenic neuropeptide neurons remain under the control of the circadian timing system and are highly sensitive to various stressors, therefore the potential neuronal mechanisms through which disturbances in the daily rhythmicity and stress-related mediator levels contribute to food intake abnormalities rely on reciprocal interactions between these elements.

Keywords: agouti-related peptide, circadian timing system, HPA-axis, neuropeptide Y, melanin-concentrating hormone, orexin, relaxin-3

Introduction

Circadian (~24 h) fluctuations of different components of the external environment, in particular light-dark conditions, shape animals' physiology and behavior for the optimal synchronization to the cyclical changes encountered. As a consequence of this influence, biological processes called circadian rhythms developed in most organisms (Vaze and Sharma, 2013). In mammals, circadian rhythms are shaped by the master circadian pacemaker, the suprachiasmatic nucleus (SCN), and secondary circadian clocks in brain and peripheral areas (Schibler et al., 2003; Mendoza and Challet, 2009). The SCN coordinates secondary clocks through neural and endocrine pathways, and glucocorticoids released from the adrenal cortex play a key role in the coordination of the circadian timing system (Balsalobre et al., 2000; Barclay et al., 2012). Importantly, mediators of the hypothalamic-pituitary-adrenal (HPA) axis, a key regulator of stress responses, directly and indirectly influence both the circadian timing system and brain centers responsible for food intake control (Dallman et al., 1995; Balsalobre et al., 2000; Segall et al., 2009; Nader et al., 2010).

In the industrialized world, chronic exposure to psychological stress, work/activity during late-night hours, and the introduction of artificial light and resultant sleep reduction, all lead to disturbances in the circadian rhythmicity in HPA-axis functioning (Stevens and Zhu, 2015; Koch et al., 2016). At the same time psychological stress and chronodisruption lead to disturbances in food intake-related processes (Kyrou et al., 2006; Antunes et al., 2010). Among other factors, food intake remains under the control of orexinergic neuropeptides, including agouti-related peptide, neuropeptide Y, orexin, melanin-concentrating hormone and relaxin-3, and the goal of this mini-review is to summarize current knowledge about mechanisms linking circadian rhythms, stress and orexigenic neuropeptides, which may underlie stress- and chronodisruption-induced food-intake abnormalities (Figure (Figure11).

Figure 1
Mutual relationship between the biological circadian clock, stress and orexigenic peptide systems. Circadian clock structures in the brain are under direct influence of the stress HPA-axis mediators: corticotropin-releasing hormone (CRH), adrenocorticotropic ...

HPA-axis rhythmicity and the circadian timing system—a mutual relationship

The HPA-axis consists of the paraventricular nucleus (PVN), the anterior lobe of the pituitary gland, and the adrenal cortex. PVN neurons synthesize corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), which stimulates secretion of adrenocorticotrophic hormone (ACTH) from the anterior pituitary and ACTH controls the release of glucocorticoids (GCs) from the adrenal cortex (Ulrich-Lai and Herman, 2009).

PVN neurons are under direct and indirect control of the SCN (Kalsbeek et al., 1992, 1996). Rhythmic release of neurotransmitters from SCN inputs to the PVN cause circadian oscillations in PVN activity (Tousson and Meissl, 2004) and daily fluctuations in CRH hnRNA and peptide levels (Owens et al., 1990; Girotti et al., 2009). ACTH plasma levels are driven by CRH secretion, but also remain under the control of the SCN (Cascio et al., 1987; Kalsbeek et al., 1996). Similarly GC release is controlled by the circadian master clock through neural control of CRH and ACTH release (Ulrich-Lai and Herman, 2009) and the autonomic innervation of the adrenal gland (Buijs et al., 1999). The rhythmic synthesis of corticosterone depends directly on the master clock, since destruction of the SCN abolishes this rhythmicity (Moore and Eichler, 1972).

Moreover, the adrenal gland has its own clock for circadian GC production (Son et al., 2008) and chronodisruption alters HPA-axis reactivity and plasma GC concentrations (Wu et al., 2008). Not surprisingly, disturbed cyclical functioning of the HPA-axis is implicated in many diseases (Chung et al., 2011). Notably, the activity of the HPA-axis exhibits ultradian rhythmicity and both ACTH and GC secretion is pulsatile in an hourly pattern (Spiga et al., 2011). Similarly to circadian fluctuations, the ultradian pattern of HPA-axis activity is crucial for proper stress responses (Sarabdjitsingh et al., 2010), however, unlike the circadian pattern, ultradian oscillations in GC secretion persist in SCN-lesioned animals and in constant light conditions (Waite et al., 2012). This uncoupling from daily rhythmicity indicates that pulsatile secretion of GC is not SCN-dependent and suggests its reliance on other oscillatory mechanisms.

Importantly, the HPA-axis reciprocally influences the circadian system. Rhythmic GC secretion synchronizes peripheral and central circadian oscillators (Balsalobre et al., 2000; Nader et al., 2010) and is crucial for the synchronization of intrinsic rhythmicity to external factors (Balsalobre et al., 2000). In the majority of tissues GCs affect the expression of clock-related genes, however GCs do not act within the SCN, where the concentration of GC-receptors is low/absent (Balsalobre et al., 2000; Pezuk et al., 2012).

Managing stress involves habituation, which provides appropriate stress coping and avoids harmful, chronic physiological consequences (Spyrka and Hess, 2010). Unfortunately, stressors that are unpredictable and experienced in high intensity lead to disruption of homeostasis, including altered circadian rhythmicity and disturbances in metabolism. One consequence of prolonged stress exposure for humans is overweight and obesity (Coccurello et al., 2009), now a major worldwide public health issue (World Health Organization, 2016). Despite increasing data concerning the reasons for and the mechanisms underlying this phenomenon, much is still to be learnt about the neuronal and humoral underpinnings of stress-induced overconsumption of food.

Central regulation of food intake: the interaction of orexigenic neuropeptide signaling, stress and circadian rhythmicity

Homeostatic regulation of food intake and energy expenditure relies on central and peripheral signals that are processed within brain centers and peripheral organs. Among many neurotransmitters involved in appetite control, centrally synthetized orexigenic neuropeptides are considered important mediators, and disturbances in their synthesis and/or signaling may contribute to malfunctioning of energy management. In the following sections, data regarding the mutual relationship between major central orexigenic neuropeptides systems, the stress-response axis and circadian systems are provided, indicating potential neuronal mechanisms involved in stress- and chronodisruption-mediated food-intake dysregulation.

Neuropeptide Y and agouti-related peptide

The arcuate nucleus (ARC) of the hypothalamus is a key appetite regulatory center (Banks, 2010). It contains two major neuronal populations, one synthesizing orexigenic neuropeptide Y (NPY) and agouti-related peptide (AgRP), and a second expressing anorexigenic proopiomelanocortin and cocaine and amphetamine-regulated transcript (Benite-Ribeiro et al., 2016).

Acute and chronic icv NPY administration result in hyperphagia, obesity and changes in metabolism (Beck et al., 1992; Su et al., 2016). Fasting increases ARC levels of NPY and AgRP mRNA (Hahn et al., 1998; Kim et al., 2005) and compromised NPY release delays physiological food intake (Krashes et al., 2013). Central AgRP injections increase feeding (Kim et al., 2000) and fasting increases the expression of AgRP mRNA and peptide (Hahn et al., 1998; Liu et al., 2012). Finally, ablation of AgRP neurons result in acute anorexia (Gropp et al., 2005) and selective activation of AgRP neurons drives feeding behavior (Krashes et al., 2011).

Both NPY and AgRP synthesis are sensitive to HPA-axis mediators. NPY levels increase after exogenous GC treatment (Larsen et al., 1994) and immobilization increases NPY mRNA in the ARC (Conrad and McEwen, 2000). Importantly, prolonged elevations in GC levels lead to overconsumption of food through inhibition of CRH and stimulation of NPY expression (Kaye et al., 1990; Cavagnini et al., 2000).

Interestingly, although AgRP and NPY are co-expressed in the same neuron, their mRNA levels are differentially regulated by stressful events. For example, footshock stress increases NPY mRNA levels, but decreases AgRP mRNA levels (Kas et al., 2005). In rats, repeated footshock (for 14 days) increases ARC AgRP mRNA levels (Helmreich et al., 2005) and chronic (4 weeks) corticosterone treatment increases hypothalamic AgRP, but not NPY, mRNA (Sefton et al., 2016). Psychological stressors, such as restraint stress, reduce the number of AgRP-expressing neurons in the ARC after both acute and repeated exposure (Chagra et al., 2011), highlighting the importance of the duration and type of stressor. Stress hormones may directly act within the ARC, since AgRP-ARC neurons are directly innervated by PVN/CRH neurons, express CRH1-receptors and CRH decreases their excitability (Kuperman et al., 2016). Similarly, GC-receptors are highly expressed in the ARC (Morimoto et al., 1996) and their activation stimulates NPY release (Yi et al., 2012) as well as NPY and AgRP gene expression (Shimizu et al., 2008).

At the same time ARC neurons innervate the PVN (Kuperman et al., 2016; Fenselau et al., 2017) and central NPY administration increases the level of CRH, ACTH and corticosterone (Alfalah and Michel, 2004). Moreover, NPY administration into the PVN stimulates food intake (Stanley and Leibowitz, 1985) and induces increased PVN neural activity (Fan et al., 2016); while sustained, viral-mediated overexpression of NPY within this structure results in obesity (Tiesjema et al., 2009). A bidirectional relationship between the HPA-axis and ARC may therefore constitute a positive feedback loop, underlying stress-induced food intake.

Importantly, ARC neuron activity is influenced by the circadian system; indirectly through HPA axis and through direct inputs from the SCN (Yi et al., 2006). Indeed, diurnal rhythm of ARC c-Fos expression (Jamali and Tramu, 1999) and enhancement of AgRP neuron activity during the active phase of the diurnal cycle was demonstrated (Krashes et al., 2013). Simultaneously, NPY/AgRP cells in the vmARC are essential for generating and maintaining circadian rhythms of ad libitum feeding (Li et al., 2012); and ARC lesions result in rest-activity disturbances (Wiater et al., 2011). Moreover, ARC NPY/AgRP circuits are crucial for the entrainment of activity by photic cues and entrainment of temperature by food (Wiater et al., 2013). Therefore, NPY/AgRP signaling is a key element of the feeding/energy homeostasis control system, through which stress and chronodisruption may influence food intake.

Orexins/hypocretins and melanin-concentrating hormone

Orexins/hypocretins are synthesized within the lateral hypothalamus (LH) (Peyron et al., 1998). Orexin neurons are involved in the control of a variety of homeostatic functions including feeding and energy expenditure (Date et al., 1999). When centrally or intraperitoneally injected, orexins stimulate food intake (Edwards et al., 1999). Fasting induces up-regulation of prepro-orexin mRNA levels (Sakurai et al., 1998), and increases the number of excitatory synapses on orexin neurons (Horvath and Gao, 2005). Chemogenetic activation of orexin neurons simultaneously increases locomotor activity and food intake (Inutsuka et al., 2014) and blockade of orexin receptors reduces food intake (Haynes et al., 2000) and binge eating behavior (Piccoli et al., 2012). Orexins are also necessary for arousal maintenance and orexins stimulate arousal-related behaviors (Hagan et al., 1999). A loss of orexin neurons leads to narcolepsy, but does not cause weight loss, and narcoleptic patients suffer abnormalities in energy metabolism and often obesity (Schuld et al., 2000). Similarly, in orexin-deficient mice, in addition to sleep/arousal cycle abnormalities, a lower level of spontaneous physical activity and obesity (regardless of hypophagia) have been described (Hara et al., 2001). Despite an orexigenic effect of acute orexin treatment, chronic icv orexin-A infusion does not lead to weight gain (Yamanaka et al., 1999). Moreover, recent findings reveal that orexin cells activity decreases after eating onset and their silencing leads to eating facilitation (González et al., 2016), which is in line with the obesity observed in orexin-deficient mice (Hara et al., 2001). However, the role of orexins in the maintenance of wakefulness during food searching and reward-related food consumption (Cason et al., 2010) highlights their importance in food intake control.

Orexin neurons are directly activated by CRH and stress (Winsky-Sommerer et al., 2004) and play a key role in stress-induced overconsumption of food (Piccoli et al., 2012), and reinstatement of alcohol- and drug-seeking behavior (Kastman et al., 2016; Schmeichel et al., 2016). The functional link between the HPA-axis and orexin neurons is reciprocal, since orexins evoke an induction of c-fos mRNA in the PVN, and an increase in plasma ACTH and corticosterone (Kuru et al., 2000). These pathways may be involved in stress-induced over-activation of orexin neurons, leading to reward-based binge eating behavior.

An accepted role of the orexin system is in the integration of circadian and metabolic influences to shape the arousal and nutritional states of the organism (Selbach and Haas, 2006). Orexins are essential for maintenance of the sleep-wake cycle (Kantor et al., 2009) and strong bidirectional neural connections exist between circadian and orexin systems. Chronodisruption may disturb orexin neuron functioning and disrupted orexin system activity may influence the circadian system. Orexin neurons receive both direct and indirect innervation from the SCN (Abrahamson et al., 2001; Deurveilher and Semba, 2005). Consequently, SCN-dependent circadian patterns are observed in brain orexin levels (Yoshida et al., 2001; Deboer et al., 2004; Zhang et al., 2004) and orexin neurons activation (Marston et al., 2008). On the other hand, SCN neurons are surrounded by orexin fibers and express orexin receptors (Belle et al., 2014). Orexins influence the activity of SCN neurons and are able to induce variable phase shifts in neonatal cultured SCN neurons and phase advances in organotypic brain slices (Klisch et al., 2009). In adult brain, orexins hyperpolarize SCN neurons and enhance the capacity of NPY to shift the phase of Period1 gene expression in adult brain slices, without an ability to induce such phase shifts alone (Belle et al., 2014). Moreover, orexins modulate the activity of structures involved in non-photic circadian entrainment such as the intergeniculate leaflet (Pekala et al., 2011; Palus et al., 2015) and dorsal raphe nucleus (Kohlmeier et al., 2013).

Within the LH, orexin neurons are intermingled with cells synthesizing melanin-concentrating hormone (MCH) (Broberger et al., 1998). Icv injections of MCH increase food intake in satiated rats (Guesdon et al., 2009), MCH knockout mice are hyperactive and lean (Shimada et al., 1998), and fasting increases levels of MCH mRNA (Bertile et al., 2003). Notably, optogenetic activation of MCH neurons in mice induces sleep, but not food consumption (Konadhode et al., 2013). However, MCH signaling can promote motivational behaviors leading to overconsumption of highly-palatable, calorically-dense food (Georgescu et al., 2005) and is involved in stress-induced binge eating (Pankevich et al., 2010), as well as cocaine (Chung et al., 2009) and alcohol (Duncan et al., 2005; Karlsson et al., 2016a,b) consumption. The involvement of MCH in food intake in animals prompted investigation of potential therapeutic effects of MCH receptor (MCHR) antagonists as anti-obesity agents in humans, but currently no compounds have proceeded to Phase II studies (Macneil, 2013).

MCH synthesis is sensitive to stress, as footshock decreases MCH mRNA levels, an effect mimicked by adrenalectomy and counteracted by dexamethasone replacement (Presse et al., 1992). Chronic mild stress in mice increases MCH-receptor expression in hippocampus (Roy et al., 2007) and repeated restraint up-regulates MCH expression (Kim and Han, 2016). Moreover, treatment of hippocampal neurons with corticosterone in vitro increases MCH expression (Kim and Han, 2016). Therefore, MCH neurons constitute another substrate through which stressors can affect feeding behavior (Hervieu, 2003).

Similar to other orexigenic peptide systems, the relationship between MCH signaling and stress is reciprocal. Blockade of MCHR1 has strong anxiolytic and antidepressant effects (Borowsky et al., 2002; Smith et al., 2006) and MCHR1 knockout mice exhibit reduced depressive-like behavior (Roy et al., 2007). Furthermore, the mode of MCH action on the stress axis depends on the circadian time, since significant activation of the HPA-axis through activation of CRH neurons and subsequent stimulation of ACTH release were observed after icv MCH injections in the early light/inactive phase (Jezova et al., 1992). Similarly, icv MCH injections during the light phase lead to increased plasma corticosterone levels and anxiety-like behavior (Smith et al., 2006) and MCHR1 antagonists reverse the effect of chronic and acute stress in mice (Smith et al., 2009; Lee et al., 2011).

In the rat, MCH mRNA expression fluctuates in a circadian manner, with a low level during the light/inactive phase and a peak after the onset of the dark/active period (Bluet-Pajot et al., 1995). MCH is a strong sleep-inducing factor (Verret et al., 2003) and MCH neurons fire during REM sleep, in direct contrast to orexin neurons (Hassani et al., 2009). Direct innervation of the MCH neurons by SCN efferents (Abrahamson et al., 2001) allows for a direct influence of the circadian master clock on MCH levels. The potential feedback of MCH on circadian structures still needs to be verified, but the presence of MCH-receptors on SCN neurons (Chee et al., 2013), and reciprocal connections with neurons influencing circadian clock function, notably orexins neurons (Guan et al., 2002), supports the assumption of a reciprocal interaction of circadian and MCH systems.

The circadian clock control of MCH and orexins synthesis, key neuropeptides involved in stress-induced overconsumption of palatable food and drug-seeking behavior, imposes a need to monitor daily rhythmicity in studies where disturbances in reward-related behaviors are being examined.

Relaxin-3

The neuropeptide relaxin-3 is synthesized mainly in brainstem nucleus incertus (NI) neurons (Ma et al., 2007). Relaxin-3 is highly-conserved, with similarities in distribution between mammalian species, including non-human primate and human brain (Ma et al., 2016), which suggest conservation of its function. Relaxin-3 regulates a variety of physiological processes, including stress responses, motivated behaviors, learning and memory, and food intake (Ma et al., 2016).

An orexigenic effect of relaxin-3 was first described by McGowan et al. (2005) who demonstrated that relaxin-3 was “equipotent” with ghrelin and NPY following icv administration. Further studies confirmed an orexigenic action of relaxin-3 injections (Hida et al., 2006) with higher sensitivity of females to the orexigenic effects of relaxin-3 (Calvez et al., 2015, 2016a). An important site for the orexigenic action of relaxin-3 is the PVN, since intra-PVN injection of the peptide (McGowan et al., 2005, 2006), and virally-mediated secretion of relaxin-3 receptor (RXFP3) agonist within the PVN (Ganella et al., 2013) increases food intake and body weight in rats. The orexigenic action of RXFP3 activation likely involves inhibition of anorexigenic oxytocin (OT) and arginine vasopressin (AVP) synthesis, since a robust reduction in OT and AVP mRNA levels was observed in response to RXFP3 activation in the PVN (Ganella et al., 2013) and relaxin-3 has an inhibitory action on PVN OT and AVP neurons in vitro (Kania et al., 2017).

Neurons in the NI are highly sensitive to stress and increases in relaxin-3 mRNA, hnRNA and peptide were observed after both physical (Calvez et al., 2016b) and psychological stressors (Tanaka et al., 2005; Banerjee et al., 2010; Lenglos et al., 2013). Moreover, a majority of relaxin-3 neurons in NI and PAG express CRH1-receptors and are excited by CRH injections in vivo and in vitro (Tanaka et al., 2005; Blasiak et al., 2013; Ma et al., 2013). The relaxin-3/RXFP3 system plays a role in stress-induced binge eating (Lenglos et al., 2013; Calvez et al., 2016b) and stress-induced reinstatement of alcohol seeking (Ryan et al., 2013; Kastman et al., 2016; Walker et al., 2016). Relaxin-3/RXFP3 signaling may reciprocally influence stress responses since icv injections of relaxin-3 in male rats result in increased c-fos and CRH mRNA expression in PVN neurons and increased plasma ACTH and corticosterone levels (Watanabe et al., 2011; McGowan et al., 2014; Lenglos et al., 2015). The overall data suggest an important role of relaxin-3 in mechanisms underlying stress influences on food intake related processes.

A growing body of evidence suggests a link between the relaxin-3 system and circadian-related processes and circadian clock structures. Relaxin-3 positive nerve fibers/terminals are present in the main neuronal structures of the circadian system; SCN, IGL and raphe nuclei (Ma et al., 2007) and in vitro relaxin-3 receptor activation alters the electrical activity of IGL neurons (Blasiak et al., 2013), which innervate the SCN. Relaxin-3 and RXFP3 knockout mice display reduced voluntary running wheel activity during the dark/active phase (Smith et al., 2012; Hosken et al., 2015) and activation of relaxin-3 receptors promotes arousal (Smith et al., 2013). Currently, there are no reports of a circadian rhythmicity in relaxin-3 levels, but sensitivity of relaxin-3 neurons to neuropeptides synthetized in a circadian manner, such as CRH and orexins (Blasiak et al., 2013, 2015) suggest that relaxin-3 expression and/or excitability of NI relaxin-3 neurons may vary over the 24-h cycle.

In conclusion, excessive and prolonged stress experienced on an everyday basis leads to circadian and metabolic disturbances, which constitute overweight and obesity risk factors (Kyrou et al., 2006; Antunes et al., 2010). Considerable experimental evidence indicates that the orexigenic neuropeptides, as critical regulators of energy homeostasis, are important elements of stress- and chronodisruption-induced malfunctioning of feeding behavior. Importantly, the circadian clock, HPA-axis and orexigenic neuropeptide systems display extensive crosstalk, and a better understanding of the mechanisms that control these mutual relationships is necessary for improving treatment strategies for food intake related disorders.

Author contributions

AB proposed the concept, reviewed the literature, and wrote the manuscript; ALG, GH, and MHL discussed the concept and revised the manuscript critically. All authors accepted the final version of the article.

Funding

This work was supported by statutory funds of the Institute of Zoology, Jagiellonian University (AB, MHL), by statutory funds of the Institute of Pharmacology, Polish Academy of Sciences (GH) and by National Health and Medical Research Council of Australia Project Grant 1067522 and Research Fellowship 1005985 (ALG).

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • Abrahamson E. E., Leak R. K., Moore R. Y. (2001). The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12, 435–440. 10.1097/00001756-200102120-00048 [PubMed] [Cross Ref]
  • Alfalah M., Michel M. C. (2004). Neuropeptide Y and Related Peptides. Berlin; New York, NY: Springer.
  • Antunes L. C., Levandovski R., Dantas G., Caumo W., Hidalgo M. P. (2010). Obesity and shift work: chronobiological aspects. Nutrition Res Rev. 23, 155–168. 10.1017/S0954422410000016 [PubMed] [Cross Ref]
  • Balsalobre A., Brown S. A., Marcacci L., Tronche F., Kellendonk C., Reichardt H. M., et al. . (2000). Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289, 2344–2347. 10.1126/science.289.5488.2344 [PubMed] [Cross Ref]
  • Banerjee A., Shen P. J., Ma S., Bathgate R. A., Gundlach A. L. (2010). Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58, 145–155. 10.1016/j.neuropharm.2009.06.019 [PubMed] [Cross Ref]
  • Banks W. A. (2010). Blood-brain barrier as a regulatory interface. Forum Nutr. 63, 102–110. 10.1159/000264398 [PubMed] [Cross Ref]
  • Barclay J. L., Tsang A. H., Oster H. (2012). Interaction of central and peripheral clocks in physiological regulation. Prog. Brain Res. 199, 163–181. 10.1016/B978-0-444-59427-3.00030-7 [PubMed] [Cross Ref]
  • Beck B., Stricker-Krongrad A., Nicolas J. P., Burlet C. (1992). Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 16, 295–302. [PubMed]
  • Belle M. D., Hughes A. T., Bechtold D. A., Cunningham P., Pierucci M., Burdakov D., et al. . (2014). Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock. J. Neurosci. 34, 3607–3621. 10.1523/JNEUROSCI.3388-13.2014 [PMC free article] [PubMed] [Cross Ref]
  • Benite-Ribeiro S. A., Putt D. A., Soares-Filho M. C., Santos J. M. (2016). The link between hypothalamic epigenetic modifications and long-term feeding control. Appetite 107, 445–453. 10.1016/j.appet.2016.08.111 [PubMed] [Cross Ref]
  • Bertile F., Oudart H., Criscuolo F., Maho Y. L., Raclot T. (2003). Hypothalamic gene expression in long-term fasted rats: relationship with body fat. Biochem. Biophys. Res. Commun. 303, 1106–1113. 10.1016/S0006-291X(03)00481-9 [PubMed] [Cross Ref]
  • Blasiak A., Blasiak T., Lewandowski M. H., Hossain M. A., Wade J. D., Gundlach A. L. (2013). Relaxin-3 innervation of the intergeniculate leaflet of the rat thalamus - neuronal tract-tracing and in vitro electrophysiological studies. Eur. J. Neurosci. 37, 1284–1294. 10.1111/ejn.12155 [PubMed] [Cross Ref]
  • Blasiak A., Siwiec M., Grabowiecka A., Blasiak T., Czerw A., Blasiak E., et al. . (2015). Excitatory orexinergic innervation of rat nucleus incertus - Implications for ascending arousal, motivation and feeding control. Neuropharmacology 99, 432–447. 10.1016/j.neuropharm.2015.08.014 [PubMed] [Cross Ref]
  • Bluet-Pajot M. T., Presse F., Voko Z., Hoeger C., Mounier F., Epelbaum J., et al. . (1995). Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. J. Neuroendocrinol. 7, 297–303. 10.1111/j.1365-2826.1995.tb00761.x [PubMed] [Cross Ref]
  • Borowsky B., Durkin M. M., Ogozalek K., Marzabadi M. R., DeLeon J., Lagu B., et al. . (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 8, 825–830. 10.1038/nm0902-1039b [PubMed] [Cross Ref]
  • Broberger C., De Lecea L., Sutcliffe J. G., Hokfelt T. (1998). Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 402, 460–474 [PubMed]
  • Buijs R. M., Wortel J., Van Heerikhuize J. J., Feenstra M. G., Ter Horst G. J., Romijn H. J., et al. . (1999). Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur. J. Neurosci. 11, 1535–1544. 10.1046/j.1460-9568.1999.00575.x [PubMed] [Cross Ref]
  • Calvez J., de Avila C., Guèvremont G., Timofeeva E. (2016a). Sex-specific effects of chronic administration of relaxin-3 on food intake, body weight and hypothalamo-pituitary-gonadal axis in rats. J. Neuroendocrinol. [Epub ahead of print]. 10.1111/jne.12439 [PubMed] [Cross Ref]
  • Calvez J., de Avila C., Matte L. O., Guèvremont G., Gundlach A. L., Timofeeva E. (2016b). Role of relaxin-3/RXFP3 system in stress-induced binge-like eating in female rats. Neuropharmacology 102, 207–215. 10.1016/j.neuropharm.2015.11.014 [PubMed] [Cross Ref]
  • Calvez J., Lenglos C., de Avila C., Guèvremont G., Timofeeva E. (2015). Differential effects of central administration of relaxin-3 on food intake and hypothalamic neuropeptides in male and female rats. Genes Brain Behav. 14, 550–563. 10.1111/gbb.12236 [PubMed] [Cross Ref]
  • Cascio C. S., Shinsako J., Dallman M. F. (1987). The suprachiasmatic nuclei stimulate evening ACTH secretion in the rat. Brain Res. 423, 173–178. 10.1016/0006-8993(87)90837-7 [PubMed] [Cross Ref]
  • Cason A. M., Smith R. J., Tahsili-Fahadan P., Moorman D. E., Sartor G. C., Aston-Jones G. (2010). Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol. Behav. 100, 419–428. 10.1016/j.physbeh.2010.03.009 [PMC free article] [PubMed] [Cross Ref]
  • Cavagnini F., Croci M., Putignano P., Petroni M. L., Invitti C. (2000). Glucocorticoids and neuroendocrine function. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 2), S77–S79. 10.1038/sj.ijo.0801284 [PubMed] [Cross Ref]
  • Chagra S. L., Zavala J. K., Hall M. V., Gosselink K. L. (2011). Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus. Regul. Pept. 167, 70–78. 10.1016/j.regpep.2010.11.006 [PMC free article] [PubMed] [Cross Ref]
  • Chee M. J., Pissios P., Maratos-Flier E. (2013). Neurochemical characterization of neurons expressing melanin-concentrating hormone receptor 1 in the mouse hypothalamus. J. Comp. Neurol. 521, 2208–2234. 10.1002/cne.23273 [PMC free article] [PubMed] [Cross Ref]
  • Chung S., Hopf F. W., Nagasaki H., Li C. Y., Belluzzi J. D., Bonci A., et al. . (2009). The melanin-concentrating hormone system modulates cocaine reward. Proc. Natl. Acad. Sci. U.S.A. 106, 6772–6777. 10.1073/pnas.0811331106 [PubMed] [Cross Ref]
  • Chung S., Son G. H., Kim K. (2011). Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim. Biophys. Acta 1812, 581–591. 10.1016/j.bbadis.2011.02.003 [PubMed] [Cross Ref]
  • Coccurello R., D'Amato F. R., Moles A. (2009). Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Neurosci. Biobehav. Rev. 33, 537–550. 10.1016/j.neubiorev.2008.05.018 [PubMed] [Cross Ref]
  • Conrad C. D., McEwen B. S. (2000). Acute stress increases neuropeptide Y mRNA within the arcuate nucleus and hilus of the dentate gyrus. Mol Brain Res. 79, 102–109. 10.1016/S0169-328X(00)00105-4 [PubMed] [Cross Ref]
  • Dallman M. F., Akana S. F., Strack A. M., Hanson E. S., Sebastian R. J. (1995). The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann. N. Y. Acad. Sci. 771, 730–742. 10.1111/j.1749-6632.1995.tb44724.x [PubMed] [Cross Ref]
  • Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., et al. . (1999). Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 96, 748–753. 10.1073/pnas.96.2.748 [PubMed] [Cross Ref]
  • Deboer T., Overeem S., Visser N. A., Duindam H., Frolich M., Lammers G. J., et al. . (2004). Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience 129, 727–732. 10.1016/j.neuroscience.2004.07.049 [PubMed] [Cross Ref]
  • Deurveilher S., Semba K. (2005). Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 130, 165–183. 10.1016/j.neuroscience.2004.08.030 [PubMed] [Cross Ref]
  • Duncan E. A., Proulx K., Woods S. C. (2005). Central administration of melanin-concentrating hormone increases alcohol and sucrose/quinine intake in rats. Alcohol. Clin. Exp. Res. 29, 958–964. 10.1097/01.ALC.0000167741.42353.10 [PubMed] [Cross Ref]
  • Edwards C. M., Abusnana S., Sunter D., Murphy K. G., Ghatei M. A., Bloom S. R. (1999). The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 160, R7–R12. 10.1677/joe.0.160r007 [PubMed] [Cross Ref]
  • Fan S., Dakshinamoorthy J., Kim E. R., Xu Y., Huang C., Tong Q. (2016). An indirect action contributes to c-Fos induction in paraventricular hypothalamic nucleus by neuropeptide Y. Sci. Rep. 6:19980. 10.1038/srep19980 [PMC free article] [PubMed] [Cross Ref]
  • Fenselau H., Campbell J. N., Verstegen A. M., Madara J. C., Xu J., Shah B. P., et al. . (2017). A rapidly acting glutamatergic ARC → PVH satiety circuit postsynaptically regulated by alpha-MSH. Nat. Neurosci. 20, 42–45. 10.1038/nn.4442 [PMC free article] [PubMed] [Cross Ref]
  • Ganella D. E., Callander G. E., Ma S., Bye C. R., Gundlach A. L., Bathgate R. A. (2013). Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Ther. 20, 703–716. 10.1038/gt.2012.83 [PubMed] [Cross Ref]
  • Georgescu D., Sears R. M., Hommel J. D., Barrot M., Bolanos C. A., Marsh D. J., et al. . (2005). The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 25, 2933–2940. 10.1523/JNEUROSCI.1714-04.2005 [PubMed] [Cross Ref]
  • Girotti M., Weinberg M. S., Spencer R. L. (2009). Diurnal expression of functional and clock-related genes throughout the rat HPA axis: system-wide shifts in response to a restricted feeding schedule. Am. J. Physiol. Endocrinol. Metab. 296, E888–E897. 10.1152/ajpendo.90946.2008 [PubMed] [Cross Ref]
  • González J. A., Jensen L. T., Iordanidou P., Strom M., Fugger L., Burdakov D. (2016). Inhibitory interplay between orexin neurons and eating. Curr. Biol. 26, 2486–2491. 10.1016/j.cub.2016.07.013 [PMC free article] [PubMed] [Cross Ref]
  • Gropp E., Shanabrough M., Borok E., Xu A. W., Janoschek R., Buch T., et al. . (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8, 1289–1291. 10.1038/nn1548 [PubMed] [Cross Ref]
  • Guan J. L., Uehara K., Lu S., Wang Q. P., Funahashi H., Sakurai T., et al. . (2002). Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int. J. Obes. Relat. Metab. Disord. 26, 1523–1532. 10.1038/sj.ijo.0802155 [PubMed] [Cross Ref]
  • Guesdon B., Paradis E., Samson P., Richard D. (2009). Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R469–R475. 10.1152/ajpregu.90556.2008 [PubMed] [Cross Ref]
  • Hagan J. J., Leslie R. A., Patel S., Evans M. L., Wattam T. A., Holmes S., et al. . (1999). Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 96, 10911–10916. 10.1073/pnas.96.19.10911 [PubMed] [Cross Ref]
  • Hahn T. M., Breininger J. F., Baskin D. G., Schwartz M. W. (1998). Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1, 271–272. 10.1038/1082 [PubMed] [Cross Ref]
  • Hara J., Beuckmann C. T., Nambu T., Willie J. T., Chemelli R. M., Sinton C. M., et al. . (2001). Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345–354. 10.1016/S0896-6273(01)00293-8 [PubMed] [Cross Ref]
  • Hassani O. K., Lee M. G., Jones B. E. (2009). Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc. Natl. Acad. Sci. U.S.A. 106, 2418–2422. 10.1073/pnas.0811400106 [PubMed] [Cross Ref]
  • Haynes A. C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R. A., et al. . (2000). A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96, 45–51. 10.1016/S0167-0115(00)00199-3 [PubMed] [Cross Ref]
  • Helmreich D. L., Parfitt D. B., Lu X. Y., Akil H., Watson S. J. (2005). Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology 81, 183–192. 10.1159/000087001 [PubMed] [Cross Ref]
  • Hervieu G. (2003). Melanin-concentrating hormone functions in the nervous system: food intake and stress. Expert Opin. Ther. Targets 7, 495–511. 10.1517/14728222.7.4.495 [PubMed] [Cross Ref]
  • Hida T., Takahashi E., Shikata K., Hirohashi T., Sawai T., Seiki T., et al. . (2006). Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J. Recept. Signal Transduct. Res. 26, 147–158. 10.1080/10799890600623373 [PubMed] [Cross Ref]
  • Horvath T. L., Gao X. B. (2005). Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab. 1, 279–286. 10.1016/j.cmet.2005.03.003 [PubMed] [Cross Ref]
  • Hosken I. T., Sutton S. W., Smith C. M., Gundlach A. L. (2015). Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal. Behav. Brain Res. 278, 167–175. 10.1016/j.bbr.2014.09.028 [PubMed] [Cross Ref]
  • Inutsuka A., Inui A., Tabuchi S., Tsunematsu T., Lazarus M., Yamanaka A. (2014). Concurrent and robust regulation of feeding behaviors and metabolism by orexin neurons. Neuropharmacology 85, 451–460. 10.1016/j.neuropharm.2014.06.015 [PubMed] [Cross Ref]
  • Jamali K. A., Tramu G. (1999). Control of rat hypothalamic pro-opiomelanocortin neurons by a circadian clock that is entrained by the daily light-off signal. Neuroscience 93, 1051–1061. 10.1016/S0306-4522(99)00208-0 [PubMed] [Cross Ref]
  • Jezova D., Bartanusz V., Westergren I., Johansson B. B., Rivier J., Vale W., et al. . (1992). Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 130, 1024–1029. [PubMed]
  • Kalsbeek A., Buijs R. M., van Heerikhuize J. J., Arts M., van der Woude T. P. (1992). Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580, 62–67. 10.1016/0006-8993(92)90927-2 [PubMed] [Cross Ref]
  • Kalsbeek A., van Heerikhuize J. J., Wortel J., Buijs R. M. (1996). A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J. Neurosci. 16, 5555–5565. [PubMed]
  • Kania A., Czerw A., Grabowiecka A., de Avila C., Blasiak T., Rajfur Z., et al. (2017). Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3/RXFP3 signalling. J. Physiol. [Epub ahead of print]. 10.1113/jp273787 [PubMed] [Cross Ref]
  • Kantor S., Mochizuki T., Janisiewicz A. M., Clark E., Nishino S., Scammell T. E. (2009). Orexin neurons are necessary for the circadian control of REM sleep. Sleep 32, 1127–1134. 10.1093/sleep/32.9.1127 [PubMed] [Cross Ref]
  • Karlsson C., Aziz A. M., Rehman F., Pitcairn C., Barchiesi R., Barbier E., et al. . (2016a). Melanin-concentrating hormone and its MCH-1 receptor: relationship between effects on alcohol and caloric intake. Alcohol. Clin. Exp. Res. 40, 2199–2207. 10.1111/acer.13181 [PubMed] [Cross Ref]
  • Karlsson C., Rehman F., Damdazic R., Atkins A. L., Schank J. R., Gehlert D. R., et al. . (2016b). The melanin-concentrating hormone-1 receptor modulates alcohol-induced reward and DARPP-32 phosphorylation. Psychopharmacology 233, 2355–2363. 10.1007/s00213-016-4285-y [PubMed] [Cross Ref]
  • Kas M. J., Bruijnzeel A. W., Haanstra J. R., Wiegant V. M., Adan R. A. (2005). Differential regulation of agouti-related protein and neuropeptide Y in hypothalamic neurons following a stressful event. J. Mol. Endocrinol. 35, 159–164. 10.1677/jme.1.01819 [PubMed] [Cross Ref]
  • Kastman H. E., Blasiak A., Walker L., Siwiec M., Krstew E. V., Gundlach A. L., et al. . (2016). Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats. Neuropharmacology 110, 82–91. 10.1016/j.neuropharm.2016.07.006 [PubMed] [Cross Ref]
  • Kaye W. H., Berrettini W., Gwirtsman H., George D. T. (1990). Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch. Gen. Psychiatry 47, 548–556. 10.1001/archpsyc.1990.01810180048008 [PubMed] [Cross Ref]
  • Kim H. J., Lee J. H., Choi S. H., Lee Y. S., Jahng J. W. (2005). Fasting-induced increases of arcuate NPY mRNA and plasma corticosterone are blunted in the rat experienced neonatal maternal separation. Neuropeptides 39, 587–594. 10.1016/j.npep.2005.09.003 [PubMed] [Cross Ref]
  • Kim M. S., Rossi M., Abusnana S., Sunter D., Morgan D. G., Small C. J., et al. . (2000). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49, 177–182. 10.2337/diabetes.49.2.177 [PubMed] [Cross Ref]
  • Kim T. K., Han P. L. (2016). Physical exercise counteracts stress-induced upregulation of melanin-concentrating hormone in the brain and stress-induced persisting anxiety-like behaviors. Exp. Neurobiol. 25, 163–173. 10.5607/en.2016.25.4.163 [PMC free article] [PubMed] [Cross Ref]
  • Klisch C., Inyushkin A., Mordel J., Karnas D., Pevet P., Meissl H. (2009). Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro. Eur. J. Neurosci. 30, 65–75. 10.1111/j.1460-9568.2009.06794.x [PubMed] [Cross Ref]
  • Koch C. E., Leinweber B., Drengberg B. C., Blaum C., Oster H. (2016). Interaction between circadian rhythms and stress. Neurobiol. Stress. 6, 57–67. 10.1016/j.ynstr.2016.09.001 [PMC free article] [PubMed] [Cross Ref]
  • Kohlmeier K. A., Tyler C. J., Kalogiannis M., Ishibashi M., Kristensen M. P., Gumenchuk I., et al. . (2013). Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front. Neurosci. 7:246. 10.3389/fnins.2013.00246 [PMC free article] [PubMed] [Cross Ref]
  • Konadhode R. R., Pelluru D., Blanco-Centurion C., Zayachkivsky A., Liu M., Uhde T., et al. . (2013). Optogenetic stimulation of MCH neurons increases sleep. J. Neurosci. 33, 10257–10263. 10.1523/JNEUROSCI.1225-13.2013 [PMC free article] [PubMed] [Cross Ref]
  • Krashes M. J., Koda S., Ye C., Rogan S. C., Adams A. C., Cusher D. S., et al. . (2011). Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424–1428. 10.1172/JCI46229 [PMC free article] [PubMed] [Cross Ref]
  • Krashes M. J., Shah B. P., Koda S., Lowell B. B. (2013). Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 18, 588–595. 10.1016/j.cmet.2013.09.009 [PMC free article] [PubMed] [Cross Ref]
  • Kuperman Y., Weiss M., Dine J., Staikin K., Golani O., Ramot A., et al. . (2016). CRFR1 in AgRP neurons modulates sympathetic nervous system activity to adapt to cold stress and fasting. Cell Metab. 23, 1185–1199. 10.1016/j.cmet.2016.04.017 [PMC free article] [PubMed] [Cross Ref]
  • Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I., et al. . (2000). Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11, 1977–1980. 10.1097/00001756-200006260-00034 [PubMed] [Cross Ref]
  • Kyrou I., Chrousos G. P., Tsigos C. (2006). Stress, visceral obesity, and metabolic complications. Ann. N. Y. Acad. Sci. 1083, 77–110. 10.1196/annals.1367.008 [PubMed] [Cross Ref]
  • Larsen P. J., Jessop D. S., Chowdrey H. S., Lightman S. L., Mikkelsen J. D. (1994). Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J. Neuroendocrinol. 6, 153–159. 10.1111/j.1365-2826.1994.tb00566.x [PubMed] [Cross Ref]
  • Lee C., Parks G. S., Civelli O. (2011). Anxiolytic effects of the MCH1R antagonist TPI 1361-17. J. Mol. Neurosci. 43, 132–137. 10.1007/s12031-010-9425-y [PMC free article] [PubMed] [Cross Ref]
  • Lenglos C., Calvez J., Timofeeva E. (2015). Sex-specific effects of relaxin-3 on food intake and brain expression of corticotropin-releasing factor in rats. Endocrinology 156, 523–533. 10.1210/en.2014-1743 [PubMed] [Cross Ref]
  • Lenglos C., Mitra A., Guevremont G., Timofeeva E. (2013). Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats. Genes Brain Behav. 12, 370–387. 10.1111/gbb.12028 [PubMed] [Cross Ref]
  • Li A. J., Wiater M. F., Oostrom M. T., Smith B. R., Wang Q., Dinh T. T., et al. . (2012). Leptin-sensitive neurons in the arcuate nuclei contribute to endogenous feeding rhythms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R1313–R1326. 10.1152/ajpregu.00086.2012 [PubMed] [Cross Ref]
  • Liu T., Kong D., Shah B. P., Ye C., Koda S., Saunders A., et al. . (2012). Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone. Neuron 73, 511–522. 10.1016/j.neuron.2011.11.027 [PMC free article] [PubMed] [Cross Ref]
  • Ma S., Blasiak A., Olucha-Bordonau F. E., Verberne A. J., Gundlach A. L. (2013). Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat. J. Physiol. 591, 3981–4001. 10.1113/jphysiol.2013.254300 [PubMed] [Cross Ref]
  • Ma S., Bonaventure P., Ferraro T., Shen P. J., Burazin T. C., Bathgate R. A., et al. . (2007). Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience. 144, 165–190. 10.1016/j.neuroscience.2006.08.072 [PubMed] [Cross Ref]
  • Ma S., Smith C. M., Blasiak A., Gundlach A. L. (2016). Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain. Br. J. Pharmacol. [Epub ahead of print]. 10.1111/bph.13659 [PubMed] [Cross Ref]
  • Macneil D. J. (2013). The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front. Endocrinol. (Lausanne) 4:49. 10.3389/fendo.2013.00049 [PMC free article] [PubMed] [Cross Ref]
  • Marston O. J., Williams R. H., Canal M. M., Samuels R. E., Upton N., Piggins H. D. (2008). Circadian and dark-pulse activation of orexin/hypocretin neurons. Mol. Brain 1:19. 10.1186/1756-6606-1-19 [PMC free article] [PubMed] [Cross Ref]
  • McGowan B. M., Minnion J. S., Murphy K. G., Roy D., Stanley S. A., Dhillo W. S., et al. . (2014). Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone. J. Endocrinol. 221, 337–346. 10.1530/JOE-13-0603 [PubMed] [Cross Ref]
  • McGowan B. M., Stanley S. A., Smith K. L., Minnion J. S., Donovan J., Thompson E. L., et al. . (2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul. Pept. 136, 72–77. 10.1016/j.regpep.2006.04.009 [PubMed] [Cross Ref]
  • McGowan B. M., Stanley S. A., Smith K. L., White N. E., Connolly M. M., Thompson E. L., et al. . (2005). Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295–3300. 10.1210/en.2004-1532 [PubMed] [Cross Ref]
  • Mendoza J., Challet E. (2009). Brain clocks: from the suprachiasmatic nuclei to a cerebral network. Neuroscientist 15, 477–488. 10.1177/1073858408327808 [PubMed] [Cross Ref]
  • Moore R. Y., Eichler V. B. (1972). Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res. 42, 201–206. 10.1016/0006-8993(72)90054-6 [PubMed] [Cross Ref]
  • Morimoto M., Morita N., Ozawa H., Yokoyama K., Kawata M. (1996). Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 26, 235–269. 10.1016/S0168-0102(96)01105-4 [PubMed] [Cross Ref]
  • Nader N., Chrousos G. P., Kino T. (2010). Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 21, 277–286. 10.1016/j.tem.2009.12.011 [PMC free article] [PubMed] [Cross Ref]
  • Owens M. J., Bartolome J., Schanberg S. M., Nemeroff C. B. (1990). Corticotropin-releasing factor concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: differential sensitivity to corticosterone. Neuroendocrinology 52, 626–631. 10.1159/000125655 [PubMed] [Cross Ref]
  • Palus K., Chrobok L., Lewandowski M. H. (2015). Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors. Neuroscience 300, 370–380. 10.1016/j.neuroscience.2015.05.039 [PubMed] [Cross Ref]
  • Pankevich D. E., Teegarden S. L., Hedin A. D., Jensen C. L., Bale T. L. (2010). Caloric restriction experience reprograms stress and orexigenic pathways and promotes binge eating. J. Neurosci. 30, 16399–16407. 10.1523/JNEUROSCI.1955-10.2010 [PMC free article] [PubMed] [Cross Ref]
  • Pekala D., Blasiak T., Raastad M., Lewandowski M. H. (2011). The influence of orexins on the firing rate and pattern of rat intergeniculate leaflet neurons–electrophysiological and immunohistological studies. Eur. J. Neurosci. 34, 1406–1418. 10.1111/j.1460-9568.2011.07868.x [PubMed] [Cross Ref]
  • Peyron C., Tighe D. K., van den Pol A. N., de Lecea L., Heller H. C., Sutcliffe J. G., et al. . (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996–10015. [PubMed]
  • Pezuk P., Mohawk J. A., Wang L. A., Menaker M. (2012). Glucocorticoids as entraining signals for peripheral circadian oscillators. Endocrinology 153, 4775–4783. 10.1210/en.2012-1486 [PubMed] [Cross Ref]
  • Piccoli L., Micioni Di Bonaventura M. V., Cifani C., Costantini V. J., Massagrande M., Montanari D., et al. . (2012). Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 37, 1999–2011. 10.1038/npp.2012.48 [PMC free article] [PubMed] [Cross Ref]
  • Presse F., Hervieu G., Imaki T., Sawchenko P. E., Vale W., Nahon J. L. (1992). Rat melanin-concentrating hormone messenger ribonucleic acid expression: marked changes during development and after stress and glucocorticoid stimuli. Endocrinology 131, 1241–1250. [PubMed]
  • Roy M., David N., Cueva M., Giorgetti M. (2007). A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biol. Psychiatry 61, 174–180. 10.1016/j.biopsych.2006.03.076 [PubMed] [Cross Ref]
  • Ryan P. J., Büchler E., Shabanpoor F., Hossain M. A., Wade J. D., Lawrence A. J., et al. . (2013). Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat. Behav. Brain Res. 244, 142–151. 10.1016/j.bbr.2013.01.034 [PubMed] [Cross Ref]
  • Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R. M., Tanaka H., et al. . (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585. 10.1016/S0092-8674(00)80949-6 [PubMed] [Cross Ref]
  • Sarabdjitsingh R. A., Conway-Campbell B. L., Leggett J. D., Waite E. J., Meijer O. C., de Kloet E. R., et al. . (2010). Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology 151, 5369–5379. 10.1210/en.2010-0832 [PubMed] [Cross Ref]
  • Schibler U., Ripperger J., Brown S. A. (2003). Peripheral circadian oscillators in mammals: time and food. J. Biol. Rhythms 18, 250–260. 10.1177/0748730403018003007 [PubMed] [Cross Ref]
  • Schmeichel B. E., Herman M. A., Roberto M., Koob G. F. (2016). Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats. Biol. Psychiatry. 81, 606–615. 10.1016/j.biopsych.2016.06.010 [PubMed] [Cross Ref]
  • Schuld A., Hebebrand J., Geller F., Pollmacher T. (2000). Increased body-mass index in patients with narcolepsy. Lancet 355, 1274–1275. 10.1016/S0140-6736(05)74704-8 [PubMed] [Cross Ref]
  • Sefton C., Harno E., Davies A., Small H., Allen T. J., Wray J. R., et al. . (2016). Elevated hypothalamic glucocorticoid levels are associated with obesity and hyperphagia in male mice. Endocrinology 157, 4257–4265. 10.1210/en.2016-1571 [PMC free article] [PubMed] [Cross Ref]
  • Segall L. A., Milet A., Tronche F., Amir S. (2009). Brain glucocorticoid receptors are necessary for the rhythmic expression of the clock protein, PERIOD2, in the central extended amygdala in mice. Neurosci. Lett. 457, 58–60. 10.1016/j.neulet.2009.03.083 [PubMed] [Cross Ref]
  • Selbach O., Haas H. L. (2006). Hypocretins: the timing of sleep and waking. Chronobiol. Int. 23, 63–70. 10.1080/07420520500545961 [PubMed] [Cross Ref]
  • Shimada M., Tritos N. A., Lowell B. B., Flier J. S., Maratos-Flier E. (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396, 670–674. 10.1038/25341 [PubMed] [Cross Ref]
  • Shimizu H., Arima H., Watanabe M., Goto M., Banno R., Sato I., et al. . (2008). Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 149, 4544–4553. 10.1210/en.2008-0229 [PubMed] [Cross Ref]
  • Smith C. M., Blasiak A., Ganella D. E., Chua B. E., Layfield S. L., Bathgate R. A., et al. . (2013). Viral-mediated delivery of an RXFP3 agonist into brain promotes arousal in mice. Ital. J. Anat. Embryol. 118, 42–46. 10.13128/IJAE-13890 [PubMed] [Cross Ref]
  • Smith C. M., Hosken I. T., Sutton S. W., Lawrence A. J., Gundlach A. L. (2012). Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav. 11, 94–104. 10.1111/j.1601-183X.2011.00730.x [PubMed] [Cross Ref]
  • Smith D. G., Davis R. J., Rorick-Kehn L., Morin M., Witkin J. M., McKinzie D. L., et al. . (2006). Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31, 1135–1145. 10.1038/sj.npp.1300913 [PubMed] [Cross Ref]
  • Smith D. G., Hegde L. G., Wolinsky T. D., Miller S., Papp M., Ping X., et al. . (2009). The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents. Behav. Brain Res. 197, 284–291. 10.1016/j.bbr.2008.08.026 [PubMed] [Cross Ref]
  • Son G. H., Chung S., Choe H. K., Kim H. D., Baik S. M., Lee H., et al. . (2008). Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc. Natl. Acad. Sci. U.S.A. 105, 20970–20975. 10.1073/pnas.0806962106 [PubMed] [Cross Ref]
  • Spiga F., Waite E. J., Liu Y., Kershaw Y. M., Aguilera G., Lightman S. L. (2011). ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology 152, 1448–1457. 10.1210/en.2010-1209 [PubMed] [Cross Ref]
  • Spyrka J., Hess G. (2010). Repeated restraint-induced modulation of long-term potentiation in the dentate gyrus of the mouse. Brain Res. 1320, 28–33. 10.1016/j.brainres.2010.01.031 [PubMed] [Cross Ref]
  • Stanley B. G., Leibowitz S. F. (1985). Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. U.S.A. 82, 3940–3943. 10.1073/pnas.82.11.3940 [PubMed] [Cross Ref]
  • Stevens R. G., Zhu Y. (2015). Electric light, particularly at night, disrupts human circadian rhythmicity: is that a problem? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 370, 1–9. 10.1098/rstb.2014.0120 [PMC free article] [PubMed] [Cross Ref]
  • Su Y., Foppen E., Fliers E., Kalsbeek A. (2016). Effects of Intracerebroventricular administration of neuropeptide Y on metabolic gene expression and energy metabolism in male rats. Endocrinology 157, 3070–3085. 10.1210/en.2016-1083 [PubMed] [Cross Ref]
  • Tanaka M., Iijima N., Miyamoto Y., Fukusumi S., Itoh Y., Ozawa H., et al. . (2005). Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur. J. Neurosci. 21, 1659–1670. 10.1111/j.1460-9568.2005.03980.x [PubMed] [Cross Ref]
  • Tiesjema B., la Fleur S. E., Luijendijk M. C., Adan R. A. (2009). Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity (Silver Spring) 17, 1448–1450. 10.1038/oby.2008.670 [PubMed] [Cross Ref]
  • Tousson E., Meissl H. (2004). Suprachiasmatic nuclei grafts restore the circadian rhythm in the paraventricular nucleus of the hypothalamus. J. Neurosci. 24, 2983–2988. 10.1523/JNEUROSCI.5044-03.2004 [PubMed] [Cross Ref]
  • Ulrich-Lai Y. M., Herman J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10, 397–409. 10.1038/nrn2647 [PMC free article] [PubMed] [Cross Ref]
  • Vaze K. M., Sharma V. K. (2013). On the adaptive significance of circadian clocks for their owners. Chronobiol. Int. 30, 413–433. 10.3109/07420528.2012.754457 [PubMed] [Cross Ref]
  • Verret L., Goutagny R., Fort P., Cagnon L., Salvert D., Leger L., et al. . (2003). A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci. 4:19. 10.1186/1471-2202-4-19 [PMC free article] [PubMed] [Cross Ref]
  • Waite E. J., McKenna M., Kershaw Y., Walker J. J., Cho K., Piggins H. D., et al. . (2012). Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur. J. Neurosci. 36, 3142–3150. 10.1111/j.1460-9568.2012.08213.x [PubMed] [Cross Ref]
  • Walker L. C., Kastman H. E., Koeleman J. A., Smith C. M., Perry C. J., Krstew E. V., et al. . (2016). Nucleus incertus corticotrophin-releasing factor 1 receptor signalling regulates alcohol seeking in rats. Addict. Biol. [Epub ahead of print]. 10.1111/adb.12426 [PubMed] [Cross Ref]
  • Watanabe Y., Miyamoto Y., Matsuda T., Tanaka M. (2011). Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J. Mol. Neurosci. 43, 169–174. 10.1007/s12031-010-9468-0 [PubMed] [Cross Ref]
  • Wiater M. F., Li A. J., Dinh T. T., Jansen H. T., Ritter S. (2013). Leptin-sensitive neurons in the arcuate nucleus integrate activity and temperature circadian rhythms and anticipatory responses to food restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R949–R960. 10.1152/ajpregu.00032.2013 [PubMed] [Cross Ref]
  • Wiater M. F., Mukherjee S., Li A. J., Dinh T. T., Rooney E. M., Simasko S. M., et al. . (2011). Circadian integration of sleep-wake and feeding requires NPY receptor-expressing neurons in the mediobasal hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1569–R1583. 10.1152/ajpregu.00168.2011 [PubMed] [Cross Ref]
  • Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A. J., Sakurai T., et al. . (2004). Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24, 11439–11448. 10.1523/JNEUROSCI.3459-04.2004 [PubMed] [Cross Ref]
  • World Health Organization (2016). Obesity and Overweight. [online] Available online at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html
  • Wu H., Zhao Z., Stone W. S., Huang L., Zhuang J., He B., et al. . (2008). Effects of sleep restriction periods on serum cortisol levels in healthy men. Brain Res. Bull. 77, 241–245. 10.1016/j.brainresbull.2008.07.013 [PubMed] [Cross Ref]
  • Yamanaka A., Sakurai T., Katsumoto T., Yanagisawa M., Goto K. (1999). Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res. 849, 248–252. 10.1016/S0006-8993(99)01905-8 [PubMed] [Cross Ref]
  • Yi C. X., Foppen E., Abplanalp W., Gao Y., Alkemade A., la Fleur S. E., et al. . (2012). Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes 61, 339–345. 10.2337/db11-1239 [PMC free article] [PubMed] [Cross Ref]
  • Yi C. X., van der Vliet J., Dai J., Yin G., Ru L., Buijs R. M. (2006). Ventromedial arcuate nucleus communicates peripheral metabolic information to the suprachiasmatic nucleus. Endocrinology 147, 283–294. 10.1210/en.2005-1051 [PubMed] [Cross Ref]
  • Yoshida Y., Fujiki N., Nakajima T., Ripley B., Matsumura H., Yoneda H., et al. . (2001). Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075–1081. 10.1046/j.0953-816x.2001.01725.x [PubMed] [Cross Ref]
  • Zhang S., Zeitzer J. M., Yoshida Y., Wisor J. P., Nishino S., Edgar D. M., et al. . (2004). Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 27, 619–627. 10.1093/sleep/27.4.619 [PubMed] [Cross Ref]

Articles from Frontiers in Neuroscience are provided here courtesy of Frontiers Media SA